Most gynae PCD companies in India are legitimate. A minority are not, and a larger group are simply careless in ways that cost their partners money. […]

Cranberry with D-mannose is used in recurrent urinary tract infection, and the distinction matters: it is prescribed to prevent the next episode, not to treat the […]

Iron deficiency anaemia in pregnancy is among the most commonly treated conditions in Indian antenatal practice. The clinical problem is rarely finding an iron salt that […]

Letrozole and clomiphene citrate are both first-line ovulation induction agents, but they work by different mechanisms and Indian prescribing has shifted steadily toward letrozole in PCOS. […]

Natural micronised progesterone is available in three presentations that are not interchangeable: soft-gelatin capsules, sustained-release tablets and injection. The route is a clinical decision, not a […]

Margin in gynae PCD is not one number. It splits sharply between hormonal products, where the margin is lower but the prescription repeats for months, and […]

Monopoly rights in PCD pharma mean the company appoints one distributor per territory for the products you carry, and will not appoint a second one beside […]